METHODS: One hundred and twenty patients with bacterial infections were randomly divided into meziocillin and cefuroxime groups and received therapeutic, to evaluate by pharmacoeconomic cost-effectiveness analysis.
METHODS: One hundred and twenty patients with bacterial infections were randomly divided into meziocillin and cefuroxime groups and received therapeutic, to evaluate by pharmacoeconomic cost-effectiveness analysis.
方法：根据文献选择各种细菌性感染的病人120例，随机分为美洛西林组和头孢呋辛组分别给予治疗，运用药物经济学的成本－效果分析方法进行分析评价。